<

ABSCIENCES (EPA:AB) AB Science announced today that results from masitinib study AB12003 in prostate cancer have been presented at the 2021 American Urological Association

Transparency directive : regulatory news

13/09/2021 18:04



Other stories

26/04/2024 18:37
26/04/2024 20:59
26/04/2024 19:00
26/04/2024 19:55
26/04/2024 14:19
26/04/2024 18:10
26/04/2024 18:16
26/04/2024 23:33
26/04/2024 21:33
26/04/2024 22:16
26/04/2024 18:22
26/04/2024 23:47
26/04/2024 17:57
26/04/2024 23:49
26/04/2024 14:07
26/04/2024 17:42
26/04/2024 16:56
26/04/2024 19:17
26/04/2024 20:31
26/04/2024 17:19
26/04/2024 12:30
26/04/2024 21:21
26/04/2024 22:01
26/04/2024 19:49
26/04/2024 13:08
26/04/2024 22:40
26/04/2024 23:29
26/04/2024 18:58
26/04/2024 21:33
26/04/2024 17:03
25/04/2024 19:30
26/04/2024 17:16
26/04/2024 10:24
25/04/2024 21:00
26/04/2024 13:30
26/04/2024 22:49
26/04/2024 23:47
26/04/2024 22:00